-
公开(公告)号:US09023996B2
公开(公告)日:2015-05-05
申请号:US13518779
申请日:2010-12-23
CPC分类号: C07K16/2896 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/72 , C07K2317/732
摘要: The present invention relates to anti-FLT3 antibodies with a modified Fc region comprising the amino acid substitutions 239D and 332E to enhance antibody-dependent cell cytotoxicity (ADCC) of these antibodies. The invention further relates to pharmaceutical compositions containing these antibodies, nucleic acids encoding these antibodies as well as methods of using such antibodies.
摘要翻译: 本发明涉及具有包含氨基酸取代239D和332E的修饰的Fc区的抗FLT3抗体以增强这些抗体的抗体依赖性细胞毒性(ADCC)。 本发明还涉及含有这些抗体的药物组合物,编码这些抗体的核酸以及使用这些抗体的方法。
-
公开(公告)号:US20120328612A1
公开(公告)日:2012-12-27
申请号:US13518779
申请日:2010-12-23
CPC分类号: C07K16/2896 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/72 , C07K2317/732
摘要: The present invention relates to anti-FLT3 antibodies with a modified Fc region comprising the amino acid substitutions 239D and 332E to enhance antibody-dependent cell cytotoxicity (ADCC) of these antibodies. The invention further relates to pharmaceutical compositions containing these antibodies, nucleic acids encoding these antibodies as well as methods of using such antibodies.
摘要翻译: 本发明涉及具有包含氨基酸取代239D和332E的修饰的Fc区的抗FLT3抗体以增强这些抗体的抗体依赖性细胞毒性(ADCC)。 本发明还涉及含有这些抗体的药物组合物,编码这些抗体的核酸以及使用这些抗体的方法。
-